Henry Schein Announces Retirement of Chief Administrative Officer and Appoints Chief Operating Officer

$HSIC
Medical Specialities
Health Care
Get the next $HSIC alert in real time by email
  • Gerald A. Benjamin will retire as Chief Administrative Officer
  • Michael S. Ettinger will be promoted to Chief Operating Officer

Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Gerald A. Benjamin plans to retire as Executive Vice President and Chief Administrative Officer, effective July 1, 2022, after 34 years with the Company. Mr. Benjamin, who will also retire from Henry Schein's Board of Directors at the end of his current term in May, will remain an adviser to the Company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220403005080/en/

Gerald A. Benjamin will retire as Executive Vice President and Chief Administrative Officer of Henry Schein, effective July 1, 2022. (Photo: Business Wire)

Gerald A. Benjamin will retire as Executive Vice President and Chief Administrative Officer of Henry Schein, effective July 1, 2022. (Photo: Business Wire)

In conjunction with Mr. Benjamin's retirement, Michael S. Ettinger will be promoted to Executive Vice President and Chief Operating Officer, effective July 1, 2022, reporting to Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. Mr. Ettinger joined Henry Schein in 1994 and has served as Senior Vice President, Corporate & Legal Affairs and Secretary, since 2013 and Chief of Staff since 2015, responsible for the Company's corporate affairs, communications, legal, compliance, regulatory, and security functions. Prior to his current position, he served as the Company's General Counsel. The organizational changes announced today reflect the implementation of the Company's succession plan for members of its senior corporate, shared services, and administrative teams.

Mr. Benjamin was responsible for developing and expanding the Company's world-class supply chain system, which includes the management of approximately 5.6 million square feet of properties around the world, consisting of 27 distribution centers, offices, showrooms, manufacturing, and sales space around the world. His work contributed significantly to the financial success of the Company, whose sales have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

"Gerry's steady, humble, and reliable leadership has benefited the lives of Team Schein Members and customers on a daily basis," said Mr. Bergman. "Gerry joined Henry Schein in 1988 and led the continuous transformation of our Global Services Group to meet the needs of each of our constituencies as we grew from being a private, domestic mail-order business into an international, full-service, publicly traded company with nearly 22,000 Team Schein Members and operations in 32 countries. His leadership was instrumental in maintaining the operational excellence for our customers over the years.

"After 34 years of distinguished and dedicated service to Henry Schein, Gerry has decided to spend more time with his family," Mr. Bergman said. "We are pleased that Gerry – who coined the term ‘Team Schein' and contributed so much to advancing the values and culture of the Company – will remain a member of Team Schein as an adviser following his retirement. On behalf of the Board of Directors and Team Schein, I would like to thank Gerry for his leadership and dedication to the Company. His influence on the people and performance of our company is incalculable and will be felt well into the future. Furthermore, the Company is appreciative of Gerry's planning and development of an outstanding succession plan over many years, which we are now implementing with talented next-generation leadership. Gerry's retirement is a bittersweet moment for us all, and we wish him a happy and well-deserved retirement."

"I am honored to have worked alongside Stan, the Board of Directors, the Company's Executive Management Committee members, and my fellow Team Schein Members to help grow this organization," said Mr. Benjamin. "I will miss my daily interactions with Team Schein, and I am confident that Stan, Michael, and our Team Schein Members will continue to advance our philosophy of ‘doing well by doing good'."

As Chief Operating Officer, in addition to his continuing responsibilities related to the Office of the CEO, Mr. Ettinger's direct reports will include:

  • Corporate Affairs, David Kochman, Vice President, Corporate Affairs;
  • Corporate Communications, Gerard Meuchner, Vice President, Chief Global Communications Officer;
  • Legal, Compliance & Regulatory, Walter Siegel, Senior Vice President, Chief Legal Officer;
  • Global Human Resources, Lorelei McGlynn, Senior Vice President, Chief Human Resources Officer;
  • Global Security, Shirley Taylor, Vice President, Global Chief Security and Safety Officer;
  • Global Supply Chain, Jim Mullins, Senior Vice President, Global Supply Chain; and,
  • Information Technology, Chris Pendergast, Senior Vice President, Chief Technology Officer.

"Since Michael joined our Company in 1994, he has established a well-deserved reputation for integrity, judgment, and wise counsel," said Mr. Bergman. "I am confident in Michael's talents, calm and steady leadership style, and huge respect for and credibility among all those who have had the pleasure of working with him."

"I am honored to have the opportunity to work alongside this exceptional leadership team and to build upon their extraordinary achievements," said Mr. Ettinger.

About Henry Schein, Inc.

Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With nearly 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein.

Get the next $HSIC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HSIC

DatePrice TargetRatingAnalyst
2/14/2025$80.00Equal Weight
Wells Fargo
1/6/2025$69.00 → $84.00Underperform → Buy
BofA Securities
12/4/2024$75.00Neutral
Mizuho
7/22/2024$81.00 → $92.00Neutral → Outperform
Robert W. Baird
2/26/2024$78.00Market Perform
Leerink Partners
12/12/2023$71.00 → $82.00Neutral → Overweight
JP Morgan
11/10/2023$70.00Hold → Buy
Stifel
8/8/2022$80.00Sell → Neutral
UBS
More analyst ratings

$HSIC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

    Fifth Annual Award Spotlights Up-and-Coming Athletic Trainers Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (NASDAQ:HSIC), announced today that Ian Jeffer, MS, ATC, LAT, Head Athletic Trainer at Desert Ridge High School in Mesa, Arizona, is the winner of the fifth annual Henry Schein Medical Athletics and Schools Rising Star Award. The recognition celebrates emerging athletic trainers with up to five years of experience in the Sports Medicine industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250418934421/en/From left to right: Ian Jeffer, Marissa Lucas, and Angel Picart. Mr. Jeffer was recognized f

    $HSIC
    Medical Specialities
    Health Care
  • Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2025 financial results before the stock market opens on Monday, May 5th, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on

    $HSIC
    Medical Specialities
    Health Care
  • Henry Schein Received Validation of Net-Zero Science-Based Targets

    Company Commits to Science-Based Targets to Guide Pathway for Achieving Net-Zero Emissions by 2050 Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Science Based Targets initiative (SBTi) has approved the Company's near-term and long-term science-based emissions reduction targets and has verified Henry Schein's net-zero science-based target by 2050. "Having joined the Business Ambition for 1.5⁰C initiative in 2021, Henry Schein is pleased to fulfill our commitment to set net-zero emissions reduction targets. Sustainability is deeply rooted in our corporate culture, and we unde

    $HSIC
    Medical Specialities
    Health Care

$HSIC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$HSIC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$HSIC
SEC Filings

See more

$HSIC
Leadership Updates

Live Leadership Updates

See more
  • PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

    Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

    $BAX
    $BMRN
    $EMBC
    $HSIC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Medical Specialities
  • Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

    Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthcare sector. His experience includes serving on the Audit, Finance and Compensation Committees for several public and private Boards of

    $BAX
    $BMRN
    $EMBC
    $HSIC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Medical Specialities
  • Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

    The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

    $CL
    $HSIC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care

$HSIC
Financials

Live finance-specific insights

See more
  • Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2025 financial results before the stock market opens on Monday, May 5th, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on

    $HSIC
    Medical Specialities
    Health Care
  • Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance

    Fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19 Fourth-quarter 2024 operating cash flow of $204 million; full-year 2024 operating cash flow of $848 million, up $348 million compared with 2023 2025 non-GAAP diluted EPS expected to be in the range of $4.80 to $4.94 with mid-single digit 2025 Adjusted EBITDA growth Announces new reportable segments to provide more meaningful information for investors Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial result

    $HSIC
    Medical Specialities
    Health Care
  • Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance

    KKR to become 12% common shareholder in Henry Schein Henry Schein and KKR to collaborate on range of value creation opportunities Two KKR representatives with deep sector experience to join the Henry Schein Board as independent directors Separately, Robert J. Hombach, who brings extensive financial and strategic experience in health care, has joined the Henry Schein Board as an independent director Announces preliminary unaudited fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19, and preliminary 2025 financial guidance for full-year non-GAAP EPS of low to mid single digit growth In addition, Henry Schein has increased its share repurchase progra

    $HSIC
    $KKR
    Medical Specialities
    Health Care
    Investment Managers
    Finance

$HSIC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more